English

GENOMICA CORP /DE/

EDGAR

Quarterly report (10-Q) · filed 2001-11-13

6 filing records in this dataset, filed from 2000-11-13 to 2001-11-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

385 thousand USD

2001-09-30 · USD

Exact inputs and evidence

Revenue: 385398 USD Source

Operating margin

-1,764.91%

2001-09-30 · %

Exact inputs and evidence

Operating Income: -6801931 USD Source
Revenue: 385398 USD Source

Cash and cash equivalents: 3.73 million USD 2001-09-30 Source
Exact value

3728747 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-21.8 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Net income: -24362797 USD · 2000-01-01 – 2000-12-31 Source
Net income: -19596254 USD · 2000-01-01 – 2000-09-30 Source
Net income: -5342045 USD · 2001-01-01 – 2001-03-31 Source
Net income: -5790484 USD · 2001-04-01 – 2001-06-30 Source
Net income: -5867389 USD · 2001-07-01 – 2001-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-11-13.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2000-12-31
Operating income: 3 of 11 periods available· newest 2000-12-31
Net income: 3 of 11 periods available· newest 2000-12-31
Operating cash flow: 3 of 11 periods available· newest 2000-12-31
Capital expenditure: 3 of 11 periods available· newest 2000-12-31
Total assets: 2 of 11 periods available· newest 2000-12-31
Total liabilities: 2 of 11 periods available· newest 2000-12-31
Current assets: 2 of 11 periods available· newest 2000-12-31
Current liabilities: 2 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+110.1%

Prior period

USD 781,330

1999-01-01 – 1999-12-31
Current period

USD 1.64 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

1641797 − 781330 = 860467 USD

781330 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
1641797 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Year-over-year change in Revenue: 860467 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1641797 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2345 Input fundies:Revenue: 781330 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2345
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 16.78 million

Prior period

−USD 7.58 million

1999-01-01 – 1999-12-31
Current period

−USD 24.36 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-24362797 − -7578471 = -16784326 USD

-7578471 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-24362797 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Year-over-year change in Net income: -16784326 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -24362797 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2662 Input fundies:NetIncome: -7578471 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2662
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.33 million

Prior period

−USD 5.1 million

1999-01-01 – 1999-12-31
Current period

−USD 10.43 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-10427788 − -5098681 = -5329107 USD

-5098681 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-10427788 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Year-over-year change in Operating cash flow: -5329107 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -10427788 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 Input fundies:OperatingCashFlow: -5098681 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+1,147.9%

Prior period

USD 223,480

1999-01-01 – 1999-12-31
Current period

USD 2.79 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

2788793 − 223480 = 2565313 USD

223480 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
2788793 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Year-over-year change in Capital expenditure: 2565313 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2788793 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 Input fundies:CapitalExpenditure: 223480 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 1.64 million 100% of revenue
Operating costs Derived USD 28.59 million 1,742% of revenue
Operating income −USD 26.95 million −1,642% of revenue
Tax, interest and other Derived −USD 2.59 million −158% of revenue
Net income −USD 24.36 million −1,484% of revenue

Cash

Operating cash flow −USD 10.43 million −635% of revenue
Capital expenditure USD 2.79 million 170% of revenue
Free cash flow Derived −USD 13.22 million −805% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 2,025% of revenue.
1999 Operating loss: operating costs were 1,121% of revenue.
2000 Operating loss: operating costs were 1,742% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	196892	3986877 Derived	-3789985	-35111 Derived	-3754874	-3641912 Derived	Source 1998-01-01 – 1998-12-31: 196892 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -3789985 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -3754874 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -3484817 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 157095 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	781330	8761139 Derived	-7979809	-401338 Derived	-7578471	-5322161 Derived	Source 1999-01-01 – 1999-12-31: 781330 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -7979809 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -7578471 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -5098681 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 223480 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	1641797	28592313 Derived	-26950516	-2587719 Derived	-24362797	-13216581 Derived	Source 2000-01-01 – 2000-12-31: 1641797 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -26950516 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -24362797 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -10427788 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 2788793 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.6M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	196892	Revenue: 196892 Open source
19991999-12-31	Revenue	781330	Revenue: 781330 Open source
20002000-12-31	Revenue	1641797	Revenue: 1641797 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

110.1% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 196892 Open source
19991999-12-31	Year over year	296.8%	Revenue: 781330 Open source Revenue: 196892 Open source
20002000-12-31	Year over year	110.1%	Revenue: 1641797 Open source Revenue: 781330 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,641.5% 2000

Net margin -1,483.9% 2000

Free cash flow margin -805% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-1,924.9%	Operating Income: -3789985 Open source Revenue: 196892 Open source
19991999-12-31	Operating margin	-1,021.3%	Operating Income: -7979809 Open source Revenue: 781330 Open source
20002000-12-31	Operating margin	-1,641.5%	Operating Income: -26950516 Open source Revenue: 1641797 Open source
19981998-12-31	Net margin	-1,907.1%	Net Income: -3754874 Open source Revenue: 196892 Open source
19991999-12-31	Net margin	-969.9%	Net Income: -7578471 Open source Revenue: 781330 Open source
20002000-12-31	Net margin	-1,483.9%	Net Income: -24362797 Open source Revenue: 1641797 Open source
19981998-12-31	Free cash flow margin	-1,849.7%	Revenue: 196892 Open source Operating Cash Flow: -3484817 Open source Capital Expenditure: 157095 Open source
19991999-12-31	Free cash flow margin	-681.2%	Revenue: 781330 Open source Operating Cash Flow: -5098681 Open source Capital Expenditure: 223480 Open source
20002000-12-31	Free cash flow margin	-805%	Revenue: 1641797 Open source Operating Cash Flow: -10427788 Open source Capital Expenditure: 2788793 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.4M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-3484817	Operating Cash Flow: -3484817 Open source
19991999-12-31	Operating cash flow	-5098681	Operating Cash Flow: -5098681 Open source
20002000-12-31	Operating cash flow	-10427788	Operating Cash Flow: -10427788 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13.2M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-3641912	Operating Cash Flow: -3484817 Open source Capital Expenditure: 157095 Open source
19991999-12-31	Free cash flow	-5322161	Operating Cash Flow: -5098681 Open source Capital Expenditure: 223480 Open source
20002000-12-31	Free cash flow	-13216581	Operating Cash Flow: -10427788 Open source Capital Expenditure: 2788793 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

1.9% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
19991999-12-31	Liabilities / assets	24.8%	Total Liabilities: 1873073 Open source Total Assets: 7553635 Open source
20002000-12-31	Liabilities / assets	1.9%	Total Liabilities: 2503637 Open source Total Assets: 129589776 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

40.66× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	4.27×	Current Assets: 6851370 Open source Current Liabilities: 1604916 Open source
20002000-12-31	Current assets / current liabilities	40.66×	Current Assets: 101806825 Open source Current Liabilities: 2503637 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 3.75 million Exact value Exact value: -3754874 USD 1998-01-01 – 1998-12-31: -3754874 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMICA CORP /DE/ · 1998-12-31 GENOMICA CORP /DE/ (edgar:1108915) Net Income: -3754874 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3754874 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2662 The citation records this snapshot. The page link may show a newer release later.	−USD 3.48 million Exact value Exact value: -3484817 USD 1998-01-01 – 1998-12-31: -3484817 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMICA CORP /DE/ · 1998-12-31 GENOMICA CORP /DE/ (edgar:1108915) Operating Cash Flow: -3484817 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3484817 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 The citation records this snapshot. The page link may show a newer release later.	USD 157,095 Exact value Exact value: 157095 USD 1998-01-01 – 1998-12-31: 157095 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMICA CORP /DE/ · 1998-12-31 GENOMICA CORP /DE/ (edgar:1108915) Capital Expenditure: 157095 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 157095 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.	−USD 3.64 million Calculation and evidence -3484817 − 157095 USD Exact free cash flow: -3641912 USD 1998-01-01 – 1998-12-31: -3484817 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 157095 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMICA CORP /DE/ · 1998-12-31 GENOMICA CORP /DE/ (edgar:1108915) Free cash flow: -3641912 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3484817 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 Input fundies:CapitalExpenditure: 157095 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 7.58 million Exact value Exact value: -7578471 USD 1999-01-01 – 1999-12-31: -7578471 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMICA CORP /DE/ · 1999-12-31 GENOMICA CORP /DE/ (edgar:1108915) Net Income: -7578471 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7578471 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2662 The citation records this snapshot. The page link may show a newer release later.	−USD 5.1 million Exact value Exact value: -5098681 USD 1999-01-01 – 1999-12-31: -5098681 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMICA CORP /DE/ · 1999-12-31 GENOMICA CORP /DE/ (edgar:1108915) Operating Cash Flow: -5098681 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5098681 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 The citation records this snapshot. The page link may show a newer release later.	USD 223,480 Exact value Exact value: 223480 USD 1999-01-01 – 1999-12-31: 223480 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMICA CORP /DE/ · 1999-12-31 GENOMICA CORP /DE/ (edgar:1108915) Capital Expenditure: 223480 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 223480 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.	−USD 5.32 million Calculation and evidence -5098681 − 223480 USD Exact free cash flow: -5322161 USD 1999-01-01 – 1999-12-31: -5098681 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 223480 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMICA CORP /DE/ · 1999-12-31 GENOMICA CORP /DE/ (edgar:1108915) Free cash flow: -5322161 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5098681 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 Input fundies:CapitalExpenditure: 223480 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 24.36 million Exact value Exact value: -24362797 USD 2000-01-01 – 2000-12-31: -24362797 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Net Income: -24362797 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24362797 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2662 The citation records this snapshot. The page link may show a newer release later.	−USD 10.43 million Exact value Exact value: -10427788 USD 2000-01-01 – 2000-12-31: -10427788 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Operating Cash Flow: -10427788 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10427788 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 The citation records this snapshot. The page link may show a newer release later.	USD 2.79 million Exact value Exact value: 2788793 USD 2000-01-01 – 2000-12-31: 2788793 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Capital Expenditure: 2788793 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2788793 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.	−USD 13.22 million Calculation and evidence -10427788 − 2788793 USD Exact free cash flow: -13216581 USD 2000-01-01 – 2000-12-31: -10427788 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 2788793 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMICA CORP /DE/ · 2000-12-31 GENOMICA CORP /DE/ (edgar:1108915) Free cash flow: -13216581 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T04:37:51Z Snapshot: 37ce0699cba75675e3fc6ef4a128e076c22c62352aece0098584860d9100355a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1108915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10427788 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2680 Input fundies:CapitalExpenditure: 2788793 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1108915/0000927356-01-000293.txt#2686 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

6 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001108915, 1108915, edgar:1108915

GENOMICA CORP /DE/

Latest quarter

Revenue

Operating margin

Trailing twelve months

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation